Patients with MI may be risk stratified based on their Adipsin levels, and those patients with the lowest Adipsin levels may need more aggressive anti-remodeling therapy to reduce their risk of developing adverse cardiac remodeling and heart failure. Here, CFD is linked to heart failure.